Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries?

The primary aim of this study is to explore the extent to which registry data may fulfill the evidence requirements of cost-effectiveness analysis (CEA) studies evaluating biologic therapies for the treatment of psoriatic arthritis (PsA), where trial data are lacking or insufficient. In addition, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Patton, Thomas, Bojke, Laura, Walton, Matthew, Manca, Andrea, Helliwell, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519654/
https://www.ncbi.nlm.nih.gov/pubmed/28612241
http://dx.doi.org/10.1007/s10067-017-3703-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519654/
https://www.ncbi.nlm.nih.gov/pubmed/28612241
http://dx.doi.org/10.1007/s10067-017-3703-9

Ejemplares similares